Providing service to over 1000 Pharmaceutical Companies
Established track record of IP protection
Timely project progress reports
Large scale multi-step chiral synthesis
Manufactured metric tons of API intermediates
Attentive Customer Service Team
Over 1200 patents publications citing use of our products
15,000+ specially designed research chemicals in stock
Successfully audited c-GMP facility
New Methodology Alerts
A General and Scalable Method toward Enantioenriched C2-Substituted Azetidines Using Chiral tert-Butanesulfinamides
J. Org. Chem. 2024, 89(20), 15137–15144. D. Zelch, C. M. Russo, K. J. Ruud and M. C. O’Reilly
News Release
J&W Pharmlab will be exhibiting at ACS Fall 2024 in Denver, Colorado - August 18th-22nd
March 15-18 2022, Attended Sigma "TARGET MOLECULE for 3rd Compound Challenge" competition and submitted our teams' total synthesis design and experimental procedures
July 24, 2020 our facility successfully completed annual fire extinguisher and prevention training
October 2019 Sucessfully completed Pfizer ESQ Supplier Audit